ISIN: SE0010441584 · Calliditas Therapeutics AB · © Finansinpektionen

Short Selling Alert: MILLENNIUM INTERNATIONAL MANAGEMENT LP

Message date: 7th June 2024

Termsheet of the Shortselling Transaction

As a result of the registered transaction decreased the share of the short position changed from 1,18% to 0,55%. Within the transaction history, this is the 54th adjustment of the short position since the initial commitment of 19th April 2023.
Snapshot transaction history
1,64%
1,23%
1,18%

0,55%

Seven (7) companies specializing in short selling have Calliditas Therapeutics AB on their short-selling radar. The total share of all short selling positions is 4,58%. The largest share is held by Armistice Capital LLC with 1,09%.
Weighting of the position within the overall ranking: 301

Short Selling Radar Europe

Corporate Insights | Information for investors and traders

360°
SSR reporting for: 7th June 2024

Short Selling Radar (Sweden)

Select Country

In this overview, we provide you with visually prepared and enriched with further relevant information short sale holdings for supplementary information and research purposes. The reporting requirements are defined via the specifications of corresponding guidelines and recorded by a publicly accessible register at the Financial Inspections1 . For validation of the data, consult at least a second source.

Tip: If you have a user account with ayondo, you can use the ayondo smart alerts to be notified when net short positionschange, ratings or ad-hoc announcements of listed companies via auto alert.

Short Selling Transaction Report from
7th June 2024

Termsheet of the Shortselling Transaction

As a result of the registered transaction decreased the share of the short position changed from 1,18% to 0,55%. Within the transaction history, this is the 54th adjustment of the short position since the initial commitment of 19th April 2023.
1,64%
1,23%
1,18%

0,55%

Seven (7) companies specializing in short selling have Calliditas Therapeutics AB on their short-selling radar. The total share of all short selling positions is 4,58%. The largest share is held by Armistice Capital LLC with 1,09%.
Weighting of the position within the overall ranking: 301
More info:
Short Selling Transaction Report from
31st May 2024

Termsheet of the Shortselling Transaction

As a result of the registered transaction decreased the share of the short position changed from 0,90% to 0,66%. Within the transaction history, this is the 6th adjustment of the short position since the initial commitment of 11th April 2024.
0,56%
0,62%
0,90%

0,66%

Seven (7) companies specializing in short selling have Calliditas Therapeutics AB on their short-selling radar. The total share of all short selling positions is 4,58%. The largest share is held by Armistice Capital LLC with 1,09%.
Weighting of the position within the overall ranking: 428
More info:
Short Selling Transaction Report from
29th May 2024

Termsheet of the Shortselling Transaction

As a result of the registered transaction decreased the share of the short position changed from 0,84% to 0,62%. Within the transaction history, this is the 27th adjustment of the short position since the initial commitment of 4th April 2023.
1,06%
0,96%
0,84%

0,62%

Seven (7) companies specializing in short selling have Calliditas Therapeutics AB on their short-selling radar. The total share of all short selling positions is 4,58%. The largest share is held by Armistice Capital LLC with 1,09%.
Weighting of the position within the overall ranking: 140
More info:
Short Selling Transaction Report from
12th April 2024

Termsheet of the Shortselling Transaction

As a result of the registered transaction unchanged the share of the short position changed from 0,50% to 0,50%. Within the transaction history, this is the 19th adjustment of the short position since the initial commitment of 19th August 2021.
0,50%
0,50%
0,50%

0,50%

Seven (7) companies specializing in short selling have Calliditas Therapeutics AB on their short-selling radar. The total share of all short selling positions is 4,58%. The largest share is held by Armistice Capital LLC with 1,09%.
Weighting of the position within the overall ranking: 1097
More info:
Short Selling Transaction Report from
6th March 2024

Termsheet of the Shortselling Transaction

As a result of the registered transaction decreased the share of the short position changed from 1,10% to 1,09%. Within the transaction history, this is the 16th adjustment of the short position since the initial commitment of 13th March 2023.
0,97%
1,00%
1,10%

1,09%

Seven (7) companies specializing in short selling have Calliditas Therapeutics AB on their short-selling radar. The total share of all short selling positions is 4,58%. The largest share is held by Armistice Capital LLC with 1,09%.
Weighting of the position within the overall ranking: 100
More info:
Short Selling Transaction Report from
21st December 2023

Termsheet of the Shortselling Transaction

As a result of the registered transaction decreased the share of the short position changed from 0,61% to 0,57%. Within the transaction history, this is the 52nd adjustment of the short position since the initial commitment of 29th September 2021.
0,51%
0,52%
0,61%

0,57%

Seven (7) companies specializing in short selling have Calliditas Therapeutics AB on their short-selling radar. The total share of all short selling positions is 4,58%. The largest share is held by Armistice Capital LLC with 1,09%.
Weighting of the position within the overall ranking: 144
More info:
Short Selling Transaction Report from
1st August 2023

Termsheet of the Shortselling Transaction

As a result of the registered transaction decreased the share of the short position changed from 0,60% to 0,59%. Within the transaction history, this is the 19th adjustment of the short position since the initial commitment of 26th May 2021.
<0,50%
0,51%
0,60%

0,59%

Seven (7) companies specializing in short selling have Calliditas Therapeutics AB on their short-selling radar. The total share of all short selling positions is 4,58%. The largest share is held by Armistice Capital LLC with 1,09%.
Weighting of the position within the overall ranking: 778
More info:
Short Selling Transaction Report from
16th May 2023

Termsheet of the Shortselling Transaction

As a result of the registered transaction decreased the share of the short position changed from 0,55% to <0,50%. Within the transaction history, this is the 2nd adjustment of the short position since the initial commitment of 2nd May 2023.
-%
-%
0,55%

n/a

<0,50%
Seven (7) companies specializing in short selling have Calliditas Therapeutics AB on their short-selling radar. The total share of all short selling positions is 4,58%. The largest share is held by Armistice Capital LLC with 1,09%.
Weighting of the position within the overall ranking: 622
More info:
Short Selling Transaction Report from
26th January 2022

Termsheet of the Shortselling Transaction

As a result of the registered transaction decreased the share of the short position changed from 0,50% to <0,50%. Within the transaction history, this is the 15th adjustment of the short position since the initial commitment of 12th October 2021.
0,57%
<0,50%
0,50%

n/a

<0,50%
Seven (7) companies specializing in short selling have Calliditas Therapeutics AB on their short-selling radar. The total share of all short selling positions is 4,58%. The largest share is held by Armistice Capital LLC with 1,09%.
Weighting of the position within the overall ranking: 1033
More info:
More related information
Type Total Last Made by Go to
Equity Story 0 - - EQS
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Note

The information prepared here is for informational purposes. The source data comes from the authority responsible for publication - the Swedish Financial Market Supervisory Authority Finansinspektionen (FI). Before further inclusion, e.g. in investment or investment decisions, validation via another source is recommended.


Please note that once positions fall below the 0.50% threshold, they are not reported again until the level triggering the reporting obligation is reached again. It is not apparent from the register data what the % value of the <0.50% position is. This is not updated as is the case with the Federal Gazette, for example. If a short position falls below the reporting threshold, the value is shown as n/a.

Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.